Moderna Inc (MRNA)vsNotable Labs Inc. (NTBL)
MRNA
Moderna Inc
$145.62
+1.29%
HEALTHCARE · Cap: $56.02B
NTBL
Notable Labs Inc.
$0.25
0.00%
HEALTHCARE · Cap: $2.39M
Smart Verdict
WallStSmart Research — data-driven comparison
Moderna Inc generates 711721% more annual revenue ($2.23B vs $313,000). NTBL leads profitability with a 0.0% profit margin vs -141.4%. NTBL earns a higher WallStSmart Score of 27/100 (F).
MRNA
Avoid21
out of 100
Grade: F
NTBL
Avoid27
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+70.0%
Fair Value
$134.97
Current Price
$145.62
$10.65 discount
Intrinsic value data unavailable for NTBL.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Conservative balance sheet, low leverage
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
Trading at 8.6x book value
2.1% revenue growth
Weak financial health signals
ROE of -46.6% — below average capital efficiency
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : MRNA
The strongest argument for MRNA centers on Market Cap, Debt/Equity.
Bull Case : NTBL
The strongest argument for NTBL centers on Price/Book, Debt/Equity.
Bear Case : MRNA
The primary concerns for MRNA are Price/Book, Revenue Growth, Piotroski F-Score.
Bear Case : NTBL
The primary concerns for NTBL are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
MRNA profiles as a turnaround stock while NTBL is a value play — different risk/reward profiles.
MRNA is growing revenue faster at 2.1% — sustainability is the question.
NTBL generates stronger free cash flow (-4M), providing more financial flexibility.
Monitor BIOTECHNOLOGY industry trends, competitive dynamics, and regulatory changes.
Bottom Line
NTBL scores higher overall (27/100 vs 21/100). MRNA offers better value entry with a 70.0% margin of safety. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Moderna Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
Notable Labs Inc.
HEALTHCARE · BIOTECHNOLOGY · USA
Notable Labs, Inc. is a clinical-stage platform therapeutic company that develops predictive precision medicine for cancer patients. The company is headquartered in Foster City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?